PDB42 INCRETIN-THERAPY IN ADDITION TO METFORMIN AND/OR...

PDB42 INCRETIN-THERAPY IN ADDITION TO METFORMIN AND/OR SULFONYLUREA FOR TYPE 2 DIABETES MELLITUS (T2DM): COSTEFFECTIVENESS OF LIRAGLUTIDE VERSUS EXENATIDE FROM THE PERSPECTIVE OF THE GERMAN STATUTORY HEALTH INSURANCE (SHI)

M Schlander, S Mentrup, N Lund
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)72100-3
File:
PDF, 71 KB
english, 2010
Conversion to is in progress
Conversion to is failed